Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC (PEMBRO-RT)

Clinical Trial ID NCT02492568

PubWeight™ 2.35‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02492568

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
2 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
3 PD-1/PD-L1 blockades in non-small-cell lung cancer therapy. Onco Targets Ther 2016 0.78
Next 100